Baird Medical Accelerates U.S. Expansion at NASOIE 2026
Prnewswire· 2026-03-02 13:30
Baird Medical Accelerates U.S. Expansion at NASOIE 2026 [Accessibility Statement] Skip NavigationNEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation at the 2026 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Miami, Florida. Building on successful engagements at previous NASOIE gathering ...
NU E Power Corp. Strengthens Senior Leadership to Support Delivery of Rapidly Expanding Global Energy Infrastructure Portfolio
TMX Newsfile· 2026-03-02 13:30
Vancouver, British Columbia--(Newsfile Corp. - March 2, 2026) - NU E Power Corp. (CSE: NUE) (OTC Pink: NUEPF) ("NU E" or the "Company") today announced the expansion of its senior leadership team with the appointment of a VP Strategic Finance & Investor Relations, as well as VP Origination & Operations. These appointments will support NU E in the scaling and delivery of a global portfolio of energy infrastructure assets. The company is working to rapidly advance, structure and grow its pipeline of purpose- ...
Stagwell Launches Stagwell Search+: The Industry's First Agentic Platform To Win AI Search
Accessnewswire· 2026-03-02 13:30
New media solution enables brands to win discoverability, visibility, positive sentiment, and outcomes across major AI systems NEW YORK, NY AND LONDON, UK / ACCESS Newswire / March 2, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced the global launch of Stagwell Search+, the industry's first agentic platform for AI Search experiences. Built by Assembly, Stagwell's global omnichannel media agency, in partnership with Emberos, the operating system ...
Columba drilling returns 10 meters of 503 gpt silver, 0.1% lead, 0.6% zinc and 9.88 meters of 319 gpt silver, 0.1% lead and 0.6% zinc from the Columba Drill Program
Prnewswire· 2026-03-02 13:30
continues to provide its shareholders with significant leverage to silver prices. The Company remains focused on the expansion of its current silver resources, new discoveries and the near-term economic development of its priority silver projects located in prolific mining districts in Sonora, State and Chihuahua, State, Mexico, respectively.CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:The information in this news release has been prepared as at March 1, 2026. Certain statements in this news release ...
Fluent, Inc. to Announce 2025 Fourth Quarter and Full-Year Financial Results and Host Earnings Conference Call on March 9, 2026
Globenewswire· 2026-03-02 13:30
NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. (NASDAQ: FLNT) today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2025, after the close of the U.S. financial markets on March 9, 2026. Fluent will host a conference call at 4:30 p.m. ET on the same day to discuss the results. The conference call can be accessed by phone after registering online at Fluent Conference Call or via audio at Audio Registration. The call and accompanying slide prese ...
IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas
Prnewswire· 2026-03-02 13:30
[https://mma.prnewswire.com/media/2319310/IceCure_Medical_Logo.jpg]SOURCE IceCure Medical## 21% [more press release views with Request a Demo]## Also from this source### IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026[IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that...]### IceCure Announces Thomas Hos ...
Twin Vee PowerCats Co. Reports 2025 Financial Results
Accessnewswire· 2026-03-02 13:30
FORT PIERCE, FL / ACCESS Newswire / March 2, 2026 / Twin Vee PowerCats Co. (Nasdaq:VEEE),("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today reported financial results for the year ended December 31, 2025, and provided a business update. According to the Company, fiscal 2025 marked a transition year for Twin Vee, as management executed a comprehensive operational reset. ...
CVRx Announces Late-Breaking Data and Scientific Presentations Highlighting Barostim Outcomes at the THT 2026 Annual Meeting
Globenewswire· 2026-03-02 13:30
MINNEAPOLIS, March 02, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today the schedule of scientific presentations reviewing the science and outcomes of Barostim therapy at the Technology and Heart Failure Therapeutics 2026 (THT) meeting. THT, the annual conference organized by the Cardiovascular Research Foundation® (CRF®), will b ...
Adastra Holdings Announces Agreement to Sell Assets and Resignation of Director
TMX Newsfile· 2026-03-02 13:30
Langley, British Columbia--(Newsfile Corp. - March 2, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) ("Adastra" or the "Company") announces that Adastra Labs Inc. ("Adastra Labs"), a wholly-owned subsidiary of the Company, has entered into an asset purchase agreement dated February 27, 2026 with an arm's length purchaser (the "Purchaser"), pursuant to which Adastra Labs has agreed to sell certain cryoethanol and hydrocarbon extraction and processing equipment as well as packaging and labelling machi ...
FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
Globenewswire· 2026-03-02 13:30
HOUSTON, March 02, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the issuance of a new U.S. patent entitled “Fibroblast Cell Therapy for Treatment of Osteoporosis.” The United States Patent and Trademark Office has issued U.S. ...